Lederer & Associates Investment Counsel’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Lederer & Associates Investment Counsel's AGN Position: Q4 2017 in Review
Lederer & Associates Investment Counsel sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 6,283 shares — an estimated $1.29M sold.
Lederer & Associates Investment Counsel first reported a position in AGN in Q1 2015 and held it in 7 quarters. The position peaked at $2.16M in Q2 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.
- Lederer & Associates Investment Counsel reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
- Lederer & Associates Investment Counsel sold 6,283 Allergan plc shares in Q4 2017, an estimated $1.29M.
- Lederer & Associates Investment Counsel first reported a position in Allergan plc in Q1 2015 and held it in 7 quarters.
- Lederer & Associates Investment Counsel's Allergan plc position peaked at $2.16M in Q2 2015.
- 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.
Based on Lederer & Associates Investment Counsel's 13F filing for Q4 2017, filed 11 Jan 2018.